Disparities in melanoma care exist in the United States. Disparities in provider type, patient
demographics, place of residence, insurance status, socioeconomic status, race/ethnicity …

The dermatology workforce continues to evolve to meet the growing and diversified
demands of the US population. Part 1 of this continuing medical education series is …

Importance There have been substantial improvements in the early detection, treatment, and
survival from cancer in the United States, but it is not clear to what extent patients with …

Importance In the 15 years since dermatology access was last investigated on a national
scale, the practice landscape has changed with the rise of private equity (PE) investment …

Importance Timely receipt of treatment for cancer is an important aspect of health care
quality. It is unknown how delays of surgery for melanoma vary by insurance type. Objective …

Background Acral lentiginous melanoma (ALM) is a rare melanoma subtype that
disproportionately afflicts people of colour. ALMs have a worse prognosis than other …

Brain metastases (BM) are one of the most common types of brain tumors and are a
relatively common event in the disease process for several high-incidence cancer types …

According to data from recent studies from Europe, a large percentage of patients have
restricted access to innovative medicines for metastatic melanoma. Melanoma World Society …

Background To reduce out‐of‐pocket costs, the Korean government expanded health
insurance reimbursement in anti‐cancer drugs for cancer patients in 2013. Our objective …

The effect of health insurance on management and outcomes in melanoma is unclear. Using
the National Cancer Database (NCDB), we evaluated the effect of insurance on (1) stage at …